Rye, New York (PRWEB) September 30, 2011
"We appreciate having the opportunity to serve many BioPharma clients during the five years that we supported Pathology Experts LLC as an investor and operating partner.
Unfortunately we have not been able to scale up the business in North America to a level that will meet our long term investment goals. We have noted the trend of many current and potential clients in North America entering long term agreements with large integrated CRO's which severely limits our ability to develop new business in this market. On behalf of Chiefadvisors LLC, I'd like to thank the team including our scientist experts, staff and advisory board for their efforts on behalf of Pathology Experts LLC. Dr. Cary with his global relationships and base in Europe will continue to lead Pathology Experts GmbH in providing preclinical development services," Jack Robinson, Chairman, Pathology Experts LLC.
"Five years ago we had indications that there would be ample demand to justify having an operating company in the US to support our global clients. Given the challenges facing CROs in the USA, particularly boutique, niche companies such as ours, we have decided to simplify and focus on continuing to offer our best in class preclinical development services via Pathology Experts GmbH. I want to thank Chiefadvisors LLC, specifically Jack Robinson for the wonderful advice, operations support and investment in Pathology Experts. I am excited about continuing to provide services to our clients in the future," Dr. Maurice Cary, CEO Pathology Experts GmbH.
Pathology Experts GmbH
Preclinical Development Services including Pathology, Toxicology & Troubleshooting
Advisors & Investors in Small Businesses in the Technology, Life Sciences, Consumer & Hospitality sectors that require operations management and financial support to grow to the next level.